The association between Dementia, Overactive Bladder, and anticholinergic therapy in elderly patients
Description: One in five Canadians suffers from overactive bladder (OAB). OAB is characterized by having a frequent and urgent need to urinate, sometimes with incontinence and while sleeping. OAB causes significant distress for people, and is associated with depression and a poor overall quality of life. OAB is more common as people age, and can become a significant burden for older patients who have decreased mobility and cognitive abilities. OAB and urinary incontinence are one of the leading reasons for caregiver burnout in those looking after older family members. One of the initial treatments offered for OAB are anticholinergic medications which calm the bladder, thereby reducing bothersome symptoms. In Ontario alone, there are over 113,000 new users of bladder anticholinergic medications every year.This class of drugs is associated with undesirable side effects including confusion and decreased cognitive abilities. There is mounting concern amongst prescribers and patients that prolonged use of these medications puts patients at risk for dementia. With such concerns, patients and providers need to have a clear understanding of the cognitive risks associated with anticholinergic medication use in OAB.As such, our research aims to answer the question: Does the use of anticholinergic medications for OAB increase the risk of developing dementia? We will use province-wide health records from the past 20 years to address this question. This work will advance our knowledge of the medical management of urinary problems with ageing and will help us identify better therapies to treat OAB. With an ageing population in Canada, this problem represents an important public health issue.
Amount: CA$17,500
Funding type: fellowship
Funder scheme: Master's Award: Canada Graduate Scholarships
Start date: 2018-05-01
End date: 2019-04-30
Investigator: Rano Matta (lead)
Institution: University of Toronto
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: 158738_1
OpenAlex ID: G7342215858
